Log in
Enquire now
‌

US Patent 10336831 Use of anti-endoglin antibodies for treating ocular fibrosis

Patent 10336831 was granted and assigned to Tracon Pharmaceuticals on July, 2019 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Tracon Pharmaceuticals
Tracon Pharmaceuticals
0
Current Assignee
Tracon Pharmaceuticals
Tracon Pharmaceuticals
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
103368310
Patent Inventor Names
Charles P. Theuer0
Date of Patent
July 2, 2019
0
Patent Application Number
160372820
Date Filed
July 17, 2018
0
Patent Citations Received
‌
US Patent 11590201 Endoglin peptides to treat fibrotic diseases
Patent Primary Examiner
‌
Christine J. Saoud
0
Patent abstract

The present application relates to compositions of humanized and deimmunized anti-endoglin antibodies and antigen-binding fragments thereof. One aspect relates to antibodies having one or more modifications in at least one amino acid residue of at least one of the framework regions of the variable heavy chain, the variable light chain or both. Another aspect relates to anti-endoglin antibodies which inhibit or treat fibrosis.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10336831 Use of anti-endoglin antibodies for treating ocular fibrosis

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us